302 related items for PubMed ID: 31375606
21. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
Sümegi V, Haszon I, Iványi B, Bereczki C, Papp F, Túri S.
Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
[Abstract] [Full Text] [Related]
22. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
[Abstract] [Full Text] [Related]
23. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 27; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
24. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P, Bonanni A, Ghiggeri GM.
BMJ Open; 2017 Mar 17; 7(3):e013319. PubMed ID: 28314744
[Abstract] [Full Text] [Related]
25. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
[Abstract] [Full Text] [Related]
26. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
[Abstract] [Full Text] [Related]
27. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 27; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
28. Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome.
Liu J, Shen Q, Xie L, Wang J, Li Y, Chen J, Fang X, Tang X, Qian B, Xu H.
BMJ Open; 2022 Oct 12; 12(10):e064216. PubMed ID: 36223961
[Abstract] [Full Text] [Related]
29. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 12; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
30. Non-corticosteroid treatment for nephrotic syndrome in children.
Durkan A, Hodson EM, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2005 Apr 18; (2):CD002290. PubMed ID: 15846634
[Abstract] [Full Text] [Related]
31. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
Pediatr Nephrol; 2006 Feb 18; 21(2):201-5. PubMed ID: 16222548
[Abstract] [Full Text] [Related]
32. Non-corticosteroid treatment for nephrotic syndrome in children.
Hodson EM, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2008 Jan 23; (1):CD002290. PubMed ID: 18254005
[Abstract] [Full Text] [Related]
33. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug 23; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
34. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO, Kari JA.
Saudi Med J; 2002 Sep 23; 23(9):1101-4. PubMed ID: 12370722
[Abstract] [Full Text] [Related]
35. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov 23; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
36. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
37. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
38. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.
Dayal U, Dayal AK, Shastry JC, Raghupathy P.
Nephron; 1994 Feb 08; 66(4):408-12. PubMed ID: 8015643
[Abstract] [Full Text] [Related]
39. Levamisole in children's idiopathic nephrotic syndrome.
La Manna A, Polito C, Del Gado R, Foglia AC.
Child Nephrol Urol; 1994 Feb 08; 9(4):200-2. PubMed ID: 3255483
[Abstract] [Full Text] [Related]
40. Treatment of idiopathic nephrotic syndrome with levamisole.
Niaudet P, Drachman R, Gagnadoux MF, Broyer M.
Acta Paediatr Scand; 1984 Sep 08; 73(5):637-41. PubMed ID: 6385610
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
